Searched for
ASTELLAS
Lupin clears Mirabegron patent dispute with Astellas in $90 million deal, secures US sales continuityDrugmaker Lupin has settled a patent infringement dispute with Astellas Pharma over its Mirabegron product for $90 million. The agreement i...10 Feb, 2026, 08.44 AM IST- Japan's Nikkei falls as tech shares drag; Astellas surgesJapan's Nikkei index saw red on Thursday as technology stocks faltered, raising flags over the hefty investments tied to Artificial Intelli...05 Feb, 2026, 12.56 PM IST
- Trump tariffs on chips and drugs would hit U.S. allies in AsiaU.S. President Donald Trump plans to introduce tariffs on imported computer chips, pharmaceuticals, and steel to encourage domestic manufac...28 Jan, 2025, 05.39 PM IST
- China says detained employee of Japan firm suspected of espionage activities"This Japanese citizen is suspected of engaging in espionage activities," Mao said, adding that China had notified the Japanese embassy in ...27 Mar, 2023, 02.13 PM IST
- Nikkei closes 1% down; Japan shares end lower on profit-booking, drugmakers limit lossesThe Nikkei share average ended 0.99 per cent lower at 28,860.08, while the broader Topix fell 1.26 per cent to 1,922.98.31 May, 2021, 01.41 PM IST
- Lupin arm in pact to distribute anti-depressant drug in JapanLupin President Dr. Fabrice Egros said the Astellas agreement reinforces Kyowa's transition toward a hybrid pharmaceutical specialty care c...27 Feb, 2017, 12.46 PM IST
- Lupin in talks with Japan's Astellas, Shionogi to buy their off-patent drug brandsThe acquisition will result in a wider offering for Lupin in Japanese market where its sales last fiscal stood at Rs 1,364 crore.27 Jul, 2016, 05.27 AM IST
- Lupin appoints Martin Mercer as head of Latin American businessThe Latin American region is a market of strategic focus for the company and one of the fastest growing pharmaceutical markets globally, sh...26 Oct, 2015, 05.04 PM IST
- Glenmark Generics Inc files law suit to enforce licence pactThe agreement is with Triax Pharmaceuticals, Astellas Pharma Europe BV and Astellas Pharma International BV.10 Oct, 2013, 04.38 PM IST
- Glenmark gets USFDA nod for skin infections creamGlenmark Pharmaceuticals received approval from USFDA for its generic Hydrocortisone Butyrate Cream used for treating skin infections.30 Sep, 2013, 01.39 PM IST
- Glenmark settles patent suit in US over skin infection creamGlenmark Pharma said it has entered into a agreement with Triax and Astellas to resolve a patent infringement case in the US.25 May, 2011, 03.36 PM IST
- Astellas aims to emerge top player in transplantationJapan’s second-largest pharma company, the $10-billion Astellas Pharma, intends to emerge as a niche player in India.10 May, 2010, 02.15 AM IST
- Astellas Pharma Q1 profit falls on R&D costsAstellas Pharma Inc Japan's second-largest drug maker, said on Friday its quarterly operating profit fell 5 percent on higher research and ...01 Aug, 2008, 03.41 PM IST
- GSK enters into agreement with Japan-based Astellas PharmaDrug firm GlaxoSmithkline Pharmaceuticals on Monday said it has enter into a collaboration with the Japan-based Astellas Pharma Inc for sel...05 May, 2008, 10.08 PM IST
- Ranbaxy, Astellas end patent rowRanbaxy Laboratories has reached an out-of-court settlement with Japanese company Astellas and Boehringer Ingelheim to sell Flomax, a drug ...10 Nov, 2007, 02.59 AM IST
- Ranbaxy, Astellas, Boehringer reach deal over FlomaxRanbaxy Laboratories Ltd has reached an agreement with Astellas / Boehringer Ingelheim over Flomax (Tamsulosin capsules) patent.08 Nov, 2007, 01.57 PM IST
- Lupin reaches out-of-court settlement with Abbott on OmnicefDomestic pharma company Lupin has reached an out-of-court settlement with US pharma major Abbott and Japan’s Astellas Pharma for the market...20 Jun, 2007, 02.52 AM IST
Load More
